Developing the First Precision Immunotherapy
Learn about the NCI-funded research that enabled the first FDA approved precision medicine- the immune checkpoint inhibitor pembrolizumab.
Media Type: Html
- SourceUrl: https://www.cancer.gov/publishedcontent/syndication/1127139.htm
- Syndication ID: 19934
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Monday, March 23, 2020 at 07:17 PM
- Date Syndication Updated: Monday, July 06, 2020 at 06:26 AM
Embed Code Snippet
To get the embed code snippet please Login.
